These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20861205)

  • 21. [Changes in content of inflammatory cytokines and troponin I in peri-operative periods of coronary artery bypass grafting with or without cardiopulmonary bypass].
    Huang ZY; Yao B; Jiang HY; Xu MX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):168-70. PubMed ID: 15760531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inflammatory response to colloids and crystalloids used for pump priming during cardiopulmonary bypass.
    Tamayo E; Alvarez FJ; Alonso O; Castrodeza J; Bustamante R; Gómez-Herreras JI; Florez S; Rodríguez R
    Acta Anaesthesiol Scand; 2008 Oct; 52(9):1204-12. PubMed ID: 18823458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical effect of high-flow pulsatile cardiopulmonary bypass in coronary artery bypass grafting].
    Yasuda T; Sawa S; Ishikawa N; Tanaka N; Manaka K; Nakagawa K; Kanakubo K; Hikimoto T; Kawasuji M; Watanabe Y
    Kyobu Geka; 1997 Dec; 50(13):1091-4. PubMed ID: 9404106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump.
    Légaré JF; Buth KJ; King S; Wood J; Sullivan JA; Hancock Friesen C; Lee J; Stewart K; Hirsch GM
    Circulation; 2004 Feb; 109(7):887-92. PubMed ID: 14757693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].
    Hoedemaekers CW; Pickkers P; Netea MG; van Deuren M; Van der Hoeven JG
    Crit Care; 2005; 9(6):R790-7. PubMed ID: 16356228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of preoperative statin therapy on cytokines after cardiac surgery.
    Liakopoulos OJ; Dörge H; Schmitto JD; Nagorsnik U; Grabedünkel J; Schoendube FA
    Thorac Cardiovasc Surg; 2006 Jun; 54(4):250-4. PubMed ID: 16755446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxygenation and release of inflammatory mediators after off-pump compared with after on-pump coronary artery bypass surgery.
    Rasmussen BS; Laugesen H; Sollid J; Grønlund J; Rees SE; Toft E; Gjedsted J; Dethlefsen C; Tønnesen E
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1202-10. PubMed ID: 17850560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial contractile performance, preload recruitable stroke work relationships, and histomorphometric changes following off-pump and on-pump coronary bypass grafting of the left internal thoracic artery to the left anterior descending artery.
    Bittner HB; Ching PV
    Heart Surg Forum; 2003; 6(3):E52-8. PubMed ID: 12821440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective randomized study.
    Serrano CV; Souza JA; Lopes NH; Fernandes JL; Nicolau JC; Blotta MH; Ramires JA; Hueb WA
    J Crit Care; 2010 Jun; 25(2):305-12. PubMed ID: 19781902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up.
    Parolari A; Camera M; Alamanni F; Naliato M; Polvani GL; Agrifoglio M; Brambilla M; Biancardi C; Mussoni L; Biglioli P; Tremoli E
    Ann Thorac Surg; 2007 Sep; 84(3):823-8. PubMed ID: 17720383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique.
    Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R
    Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of pulsatile perfusion during cardiopulmonary bypass in pediatric heart surgery.
    Zhao J; Liu JP; Feng ZY; Liu YL; Li SJ; Long C
    ASAIO J; 2009; 55(3):300-3. PubMed ID: 19282749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
    Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A propensity score analysis on the effect of eliminating cardiopulmonary bypass for coronary artery bypass grafting.
    Crescenzi G; Landoni G; Romano A; Boroli F; Giardina G; Bignami E; Fochi O; Aletti G; Rosica C; Zangrillo A
    Minerva Anestesiol; 2007 Mar; 73(3):135-41. PubMed ID: 17384571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.
    Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac enzyme release and survival.
    Kuduvalli M; Newall N; Stott A; Grayson AD; Fabri BM
    Eur J Cardiothorac Surg; 2006 May; 29(5):729-35. PubMed ID: 16520048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fenoldopam and dopexamine on cytokine and endotoxin release following on-pump coronary artery bypass grafting: a prospective randomized double-blind trial.
    Adluri RK; Singh AV; Skoyles J; Robins A; Parton J; Baker M; Mitchell IM
    Heart Surg Forum; 2010 Dec; 13(6):E353-61. PubMed ID: 21169142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.